Recombinant fiv glycoprotein 160 and p24 gag protein

Details Recombinant fiv glycoprotein 160 and p24 gag protein Recombinant fiv glycoprotein 160 and p24 gag protein

C - Chemistry, Metallurgy

12

N

C12N 15/49 (2006.01) A61K 39/21 (2006.01) A61K 39/42 (2006.01) C07K 1/30 (2006.01) C07K 14/155 (2006.01) C07K 16/10 (2006.01) C12N 5/10 (2006.01) C12P 21/08 (2006.01) G01N 33/569 (2006.01) G01N 33/577 (2006.01)

Patent

CA 2104285

2104285 9215684 PCTABS00016 Feline immunodeficiency virus antigens from gp160 envelope protein, gp120 envelope protein and p24 gag protein, useful for the diagnosis, treatment, and prevention of FIV. The invention may also be used to purify FIV.

Affiliated with

Also associated with

Rating

Recombinant fiv glycoprotein 160 and p24 gag protein does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Recombinant fiv glycoprotein 160 and p24 gag protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant fiv glycoprotein 160 and p24 gag protein will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1616527